AllRock Bio is a startup based in the United States.
AllRock Bio is a clinical-stage biotechnology company developing a small-molecule pan-ROCK inhibitor to treat cardiopulmonary and fibrotic diseases, including pulmonary hypertension and interstitial lung disease. The company focuses on advancing therapies from development through commercialization for pulmonary and fibrotic indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.